AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.530
+0.010 (0.28%)
At close: Mar 19, 2026, 4:00 PM EDT
3.540
+0.010 (0.28%)
Pre-market: Mar 20, 2026, 5:53 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.07 billion as of March 20, 2026. Its market cap has increased by 50.26% in one year.
Market Cap
1.07B
Enterprise Value
679.55M
1-Year Change
50.26%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.07B, a decrease of -93.17%. That is a compound annual growth rate of -39.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 1.07B | 4.54% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precigen | 1.16B |
| EyePoint | 1.14B |
| ORIC Pharmaceuticals | 1.09B |
| Septerna | 1.08B |
| Tevogen Bio Holdings | 1.08B |
| Pharming Group | 1.05B |
| Savara | 1.03B |
| Bicara Therapeutics | 1.01B |